Background
Self-reactive IgG antibodies (Abs), including those targeting the CD4 protein, have been previously identified in people with HIV (PWH), and are thought to mostly originate from a repertoire of cross-reactive anti-viral Ab. However, the kinetics, potential immunological function and clinical consequences of broad IgMs and IgGs anti-lymphocyte Abs (ALAbs) still need to be addressed.
Methods
We evaluated sera and PBMC samples from a longitudinal cohort of 39 PWH (aged 24-77 years, baseline median viral load of 185,551copies/mL and CD4 count 16 cells/µL) at early (0-2 weeks) and late (80 weeks) time points after the start of antiretroviral therapy (ART) and virologic suppression. Our goals were to: 1) analyze IgG/IgM ALAb prevalence in sera using a flow-based assay, 2) quantify their potential complement-dependent cytotoxicity (CDC), 3) determine if there is a correlation between ALAb and CDC, and 4) detect potential in vivo anti-lymphocyte complement activity by analyzing complement deposition, ALAb and direct ex vivo CDC on patients’ PBMCs and assess the impact of ART.
Results
We found high prevalence of ALAbs in PWH at the early time point, predominantly anti-CD4+ and anti-CD8+ Abs (72% and 74%, respectively), that decreased after two years of ART (to 41% and 44%, respectively). These ALAb were immunologically active as patients’ sera lysed healthy control (HC) lymphocytes in a CDC assay that was dependent on IgM Ab and complement. Furthermore, IgM — but not IgG — ALAb correlated with CDC lysis of CD4-T cells (p<0.01) and CD8-T cells (p<0.05), at the early time point. This IgM-mediated CDC decreased after 80 weeks of ART and virologic suppression. In PWH PBMCs, C3b complement deposition was detected on CD4 and CD8-T cells at both the early (87% and 66%, respectively) and late time points (42% CD4-T cells and 24% CD8 T-cells, respectively). In addition, we detected ALAbs bound to patients’ CD4 and/or CD8-T cells upon ex vivo staining even at the late time point (71%). Furthermore, lymphocytes from three of these PWH were lysed directly ex vivo by addition of complement, suggesting possible in vivo CDC of lymphocytes in the post-ART time point.
Conclusions
Antilymphocyte antibodies with cytotoxic activity are common and persist on ART, albeit at lower levels. Our findings may help to understand perturbations of T-cell homeostasis and the chronic immune activation and inflammation observed in PWH on ART.
Table or Figure
